Pipeline

NAX035 is a novel and selective anticancer agent with a superior profile for oncology conditions. It is a derivative of natural alkaloid Berberine which shows superior activity and pharmacology and safety profile. It shows robust preclinical proof of concept in several in vitro and animal models.